PTU - Polskie Towarzystwo Urologiczne
home page
current numbers
archival numbers
list of articles:
list przewodni/covering letter
editor
Scientific Committee
publisher
subscription
advertising
important links

INTERSTITIAL LASER COAGULATION OF THE PROSTATE
Article published in Urologia Polska 1998/51/2.

authors

Wojciech Pypno, Wojciech Husiatyński
Klinika Urologii CMKP w Warszawie
Kierownik Kliniki: prof. dr hab. med. M. Kazoń

keywords

prostate benign prostatic hyperplasia laser treatment interstitial coagulation

summary

Objective. The evaluation of the effectiveness and the safety of interstitial
laser coagulation of the prostate (ILCP).
Patients and methods. In 30 patients with BPH interstitial laser coagulation
of the prostate was performed. Laser Nd:YAG with the programme regulated
the power was applied. The means of the intervention was described. Before
this procedure and after 1,3,6,12 and 24 months IPSS, ±uality of life, maximum
flow rate and residual urine were estimated.
Results. There were no severe complications. The follow-up was 12-24 months
average 19 months
middle on 3 patients. Only one patient did not come for control examination.
There were no poor results.
Conclusion. Interstitial laser coagulation is the no risk, one-day surgery
procedure. Effectiveness of this treatment compare to TURP.

references

  1. [1] Bown, S.G.: Phototherapy of tumours. World J. Surg. 1983,7,700-709.
  2. [2] Costello, T. G., Costello, A. J.: Anaesthesia for laser prostatectomy. Anaesth.
  3. Intensive Care 1994, 22, 454-457.
  4. [3] Garraway, W. M., Collins, G. N., Lee, R. ].: High prevalence of benign prosta-
  5. tic hypertrophy in the community. Lancet 1991, 338,469-471.
  6. [4] Johnson, D. E., Cromeens, D. M., Price, R. E.: Interstitial laser prostatectomy.
  7. Lasers Surg. Med. 1994,14, 299-305.
  8. [5] McNicholas, T. A., Steger, A. C, Bown, S. G.: Interstitial laser coagulation of
  9. the prostate. An expeńmental study. Br. J. Urol. 1993, 71,439-444.
  10. [6] Mebust, W. K., Holtgrewe, H. L., Cockett, A. T. K., Peters, P. C. and
  11. Writing Committee: Transurethral prostatectomy: Immediate and postoperatwe
  12. complications. A cooperative study of 13 participating institutions evaluating 3885
  13. patients. J. Urol. 1989,141, 243-246.
  14. [7] Muschter, R., Hessel, S., Hofstetter, A., Keiditsch, E., Rothenberger,
  15. K. H., Schneede, R, Frank, ?.: Die interstitielleLaserkoagulation der benignen
  16. Prostatahyperplasie. Urologe A 1993, 32, 273-281.
  17. [8] Muschter, R., Hofstetter, A.: Laserbehandlungder benignen Prostatahyperpla-
  18. sie. Urologe A1994,33, 281-287.
  19. [9] Muschter, R., Hofstetter, A.: Techni±ue and results of'interstitial laser coagula-
  20. tion. World J. Urol. 1995,13,109-114.
  21. [10] Muschter, R., Perlmutter, A. R: The optimization of laser prostatectomy. Partii:
  22. Other lasing techni±ues. Urology 1994,44,856-861.
  23. [11] Muschter, R., Zellner, M., Hessel, S., Hofstetter, A.: Dieinterstitiellelaser-
  24. induzierte koagulation (ILK) der Prostata zur Therapie der Benignen Hyperplasie
  25. (BPH). Urologe A1995,34,90-97.
  26. [12] Pypno, W., Husiatyński; W.: Leczenie laserem łagodnego rozrostu stercza.
  27. [w:] Zarys klinicznych zastosowań laserów. Dom Wydawniczy ?Ankar", Warsza-
  28. wa 1995, 268-278.
  29. [13] Pypno, W., Husiatyński, W.: Przezcewkowa laserowa ablacja stercza. Urol. Pol.
  30. 1996, 49, 48-52.
  31. [14] Pypno, W., Husiatyński, W., Kazoń, M.: Przezcewkowa koagulacja laserowa
  32. stercza (doniesienie wstępne). Urol. Pol. 1993,46,305-308.
  33. [15] Watson, G.: Laser prostatectomy: where are we now, and where should we be going?
  34. J. Endourol. 1995, 9,199-203.
  35. [16] Zermann, D. H., Lindner, H., Bockhorn, V., Schubert, ].:DerHochrisikopa-
  36. tient mit symptomatischer Prostatahyperplasie - ein therapeutisches Dilemma?
  37. Z. Arztl. Fortbild. (Jena) 1995, 89, 287-292.